Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5199
Gene Symbol: CFP
CFP
0.700 GeneticVariation disease UNIPROT Structural Basis for Properdin Oligomerization and Convertase Stimulation in the Human Complement System. 31507604 2019
Entrez Id: 5199
Gene Symbol: CFP
CFP
0.700 GeneticVariation disease UNIPROT Functional and structural insight into properdin control of complement alternative pathway amplification. 28264884 2017
Entrez Id: 5199
Gene Symbol: CFP
CFP
0.700 Biomarker disease GENOMICS_ENGLAND Targeted Next-Generation Sequencing Analysis of 1,000 Individuals with Intellectual Disability. 26350204 2015
Entrez Id: 5199
Gene Symbol: CFP
CFP
0.700 Biomarker disease CTD_human Molecular characterisation of 10 Dutch properdin type I deficient families: mutation analysis and X-inactivation studies. 10909851 2000
Entrez Id: 5199
Gene Symbol: CFP
CFP
0.700 GeneticVariation disease UNIPROT Molecular characterisation of 10 Dutch properdin type I deficient families: mutation analysis and X-inactivation studies. 10909851 2000
Entrez Id: 5199
Gene Symbol: CFP
CFP
0.700 GeneticVariation disease UNIPROT Expression of properdin in complete and incomplete deficiency: normal in vitro synthesis by monocytes in two cases with properdin deficiency type II due to distinct mutations. 9710744 1998
Entrez Id: 5199
Gene Symbol: CFP
CFP
0.700 GermlineCausalMutation disease ORPHANET Molecular characterization of properdin deficiency type III: dysfunction produced by a single point mutation in exon 9 of the structural gene causing a tyrosine to aspartic acid interchange. 8871668 1996
Entrez Id: 5199
Gene Symbol: CFP
CFP
0.700 GeneticVariation disease UNIPROT Molecular characterization of properdin deficiency type III: dysfunction produced by a single point mutation in exon 9 of the structural gene causing a tyrosine to aspartic acid interchange. 8871668 1996
Entrez Id: 5199
Gene Symbol: CFP
CFP
0.700 Biomarker disease CTD_human Sequence-based analysis of properdin deficiency: identification of point mutations in two phenotypic forms of an X-linked immunodeficiency. 8530058 1995
Entrez Id: 5199
Gene Symbol: CFP
CFP
0.700 CausalMutation disease CLINVAR
Entrez Id: 7040
Gene Symbol: TGFB1
TGFB1
0.030 AlteredExpression disease BEFREE In contrast, PFD significantly decreased the basal and TGF- β1-induced phosphorylation levels of p38 in DD-derived fibroblasts. 30927912 2019
Entrez Id: 7040
Gene Symbol: TGFB1
TGFB1
0.030 Biomarker disease BEFREE CCK‑8 and colony formation assays demonstrated that PFD significantly inhibited cell proliferation in HIFs stimulated with TGF‑β1. 30152848 2018
Entrez Id: 7040
Gene Symbol: TGFB1
TGFB1
0.030 Biomarker disease BEFREE PFD significantly inhibited TGF-β1-induced EMT. 28285699 2017
Entrez Id: 23659
Gene Symbol: PLA2G15
PLA2G15
0.010 Biomarker disease BEFREE Outcomes of interest include the ratio of studies adhering to the ACS NSQIP/AGS guidelines and evidence for frailty assessments versus usual care for women with PFDs. 29474287 2019
Entrez Id: 55902
Gene Symbol: ACSS2
ACSS2
0.010 Biomarker disease BEFREE Outcomes of interest include the ratio of studies adhering to the ACS NSQIP/AGS guidelines and evidence for frailty assessments versus usual care for women with PFDs. 29474287 2019
Entrez Id: 182
Gene Symbol: JAG1
JAG1
0.010 GeneticVariation disease BEFREE This study seeks to describe studies among women with PFD and the associated frailty assessments as recommended in the American College of Surgeons National Surgical Quality Improvement Program/American Geriatric Society (ACS NSQIP/AGS) guidelines. 29474287 2019
Entrez Id: 1017
Gene Symbol: CDK2
CDK2
0.010 AlteredExpression disease BEFREE CDK2 protein expression was clearly decreased in PFD-treated LNCaP and PC-3 cells, whereas p21 protein expression was increased in only PFD-treated LNCaP cells. 30621175 2019
Entrez Id: 84680
Gene Symbol: ACCS
ACCS
0.010 Biomarker disease BEFREE Outcomes of interest include the ratio of studies adhering to the ACS NSQIP/AGS guidelines and evidence for frailty assessments versus usual care for women with PFDs. 29474287 2019
Entrez Id: 6606
Gene Symbol: SMN1
SMN1
0.010 AlteredExpression disease BEFREE Treatment with PFD significantly reduced ConA-induced expression of type II and IV collagens, α-SMA mRNA expression, and HP content and decreased inflammatory cells infiltration in hepatic tissues. 31639402 2019
Entrez Id: 6607
Gene Symbol: SMN2
SMN2
0.010 AlteredExpression disease BEFREE Treatment with PFD significantly reduced ConA-induced expression of type II and IV collagens, α-SMA mRNA expression, and HP content and decreased inflammatory cells infiltration in hepatic tissues. 31639402 2019
Entrez Id: 3553
Gene Symbol: IL1B
IL1B
0.010 AlteredExpression disease BEFREE In vitro, the experiments revealed that PFD significantly suppressed LPS/ATP-induced production of reactive oxygen species (ROS) and decreased caspase-1 activation and the level of IL-1β in J774 A.1 cells. 29783158 2018
Entrez Id: 834
Gene Symbol: CASP1
CASP1
0.010 Biomarker disease BEFREE In vitro, the experiments revealed that PFD significantly suppressed LPS/ATP-induced production of reactive oxygen species (ROS) and decreased caspase-1 activation and the level of IL-1β in J774 A.1 cells. 29783158 2018